Voll Ronald J, McConathy Jonathan, Waldrep Michael S, Crowe Ronald J, Goodman Mark M
Department of Radiology, EUH, 1364 Clifton Road NE, Atlanta, GA 30322, USA.
Appl Radiat Isot. 2005 Sep;63(3):353-61. doi: 10.1016/j.apradiso.2005.04.008.
The fluorine-18 labeled dopamine transport (DAT) ligand 2 beta-carbomethoxy-3beta-(4-chlorophenyl)-8-(2-fluoroethyl)nortropane (FECNT) has shown promising properties as an in vivo DAT imaging agent in human and monkey PET studies. A semi-automated synthesis has been developed to reliably produce [(18)F]FECNT in a 16% decay corrected yield. This method utilizes a new [(18)F]fluoralkylating agent and provides high purity [(18)F]FECNT in a formulation suitable for human use.
氟-18标记的多巴胺转运体(DAT)配体2β-甲氧羰基-3β-(4-氯苯基)-8-(2-氟乙基)去甲托烷(FECNT)在人体和猴子的正电子发射断层扫描(PET)研究中已显示出作为一种体内DAT成像剂的良好特性。已开发出一种半自动合成方法,以16%的衰变校正产率可靠地生产[(18)F]FECNT。该方法使用一种新的[(18)F]氟烷基化剂,并以适合人体使用的制剂形式提供高纯度的[(18)F]FECNT。